These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36309731)

  • 1. Silencing eL31 suppresses the progression of colorectal cancer via targeting DEPDC1.
    Sharen G; Li X; Sun J; Zhang L; Xi W; Zhao X; Han F; Jia L; A R; Cheng H; Hou M
    J Transl Med; 2022 Oct; 20(1):493. PubMed ID: 36309731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DEP Domain Containing 1 Promotes Proliferation, Invasion, and Epithelial-Mesenchymal Transition in Colorectal Cancer by Enhancing Expression of Suppressor of Zest 12.
    Wang Q; Jiang S; Liu J; Ma G; Zheng J; Zhang Y
    Cancer Biother Radiopharm; 2021 Feb; 36(1):36-44. PubMed ID: 32343606
    [No Abstract]   [Full Text] [Related]  

  • 3. Overexpression of gene DEP domain containing 1 and its clinical prognostic significance in colorectal cancer.
    Shen X; Han J
    J Clin Lab Anal; 2020 Dec; 34(12):e23634. PubMed ID: 33140894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SIRT1 enhances oxaliplatin resistance in colorectal cancer through microRNA-20b-3p/DEPDC1 axis.
    Zhao B; Wang Y; Zhao X; Ni J; Zhu X; Fu Y; Yang F
    Cell Biol Int; 2022 Dec; 46(12):2107-2117. PubMed ID: 36200529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.
    Guo W; Li H; Liu H; Ma X; Yang S; Wang Z
    Oncol Rep; 2019 Sep; 42(3):1075-1089. PubMed ID: 31322256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DEPDC1 promotes cell proliferation and tumor growth via activation of E2F signaling in prostate cancer.
    Huang L; Chen K; Cai ZP; Chen FC; Shen HY; Zhao WH; Yang SJ; Chen XB; Tang GX; Lin X
    Biochem Biophys Res Commun; 2017 Aug; 490(3):707-712. PubMed ID: 28634077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DEPDC1 as a crucial factor in the progression of human osteosarcoma.
    Shen L; Li H; Liu R; Zhou C; Bretches M; Gong X; Lu L; Zhang Y; Zhao K; Ning B; Yang SY; Zhang A
    Cancer Med; 2023 Mar; 12(5):5798-5808. PubMed ID: 36479633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [DEPDC1 is Highly Expressed in Lung Adenocarcinoma and Promotes Tumor Cell Proliferation].
    Shen J; Xi M
    Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):453-460. PubMed ID: 34134185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA
    Xu W; Wang J; Xu J; Li S; Zhang R; Shen C; Xie M; Zheng B; Gu M
    J Int Med Res; 2022 Apr; 50(4):3000605221093135. PubMed ID: 35466755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DEP domain containing 1 predicts prognosis of hepatocellular carcinoma patients and regulates tumor proliferation and metastasis.
    Qu D; Cui F; Lu D; Yang Y; Xu Y
    Cancer Sci; 2019 Jan; 110(1):157-165. PubMed ID: 30417471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of the DEPDC1 oncoantigen in malignant glioma and brain tumor initiating cells.
    Kikuchi R; Sampetrean O; Saya H; Yoshida K; Toda M
    J Neurooncol; 2017 Jun; 133(2):297-307. PubMed ID: 28555424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocadherin 10 inhibits cell proliferation and induces apoptosis via regulation of DEP domain containing 1 in endometrial endometrioid carcinoma.
    Yang Y; Jiang Y; Jiang M; Zhang J; Yang B; She Y; Wang W; Deng Y; Ye Y
    Exp Mol Pathol; 2016 Apr; 100(2):344-52. PubMed ID: 26970279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DEPDC1, negatively regulated by miR-26b, facilitates cell proliferation via the up-regulation of FOXM1 expression in TNBC.
    Zhang L; Du Y; Xu S; Jiang Y; Yuan C; Zhou L; Ma X; Bai Y; Lu J; Ma J
    Cancer Lett; 2019 Feb; 442():242-251. PubMed ID: 30419349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DEPDC1 up-regulates RAS expression to inhibit autophagy in lung adenocarcinoma cells.
    Wang W; Li A; Han X; Wang Q; Guo J; Wu Y; Wang C; Huang G
    J Cell Mol Med; 2020 Nov; 24(22):13303-13313. PubMed ID: 33021072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA KTN1 antisense RNA 1exerts an oncogenic function in lung adenocarcinoma by regulating DEP domain containing 1 expression via activating epithelial-mesenchymal transition.
    Li YY; Li W; Chang GZ; Li YM
    Anticancer Drugs; 2021 Jun; 32(6):614-625. PubMed ID: 33491970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC.
    Huang C; Ou R; Chen X; Zhang Y; Li J; Liang Y; Zhu X; Liu L; Li M; Lin D; Qiu J; Liu G; Zhang L; Wu Y; Tang H; Liu Y; Liang L; Ding Y; Liao W
    J Exp Clin Cancer Res; 2021 Sep; 40(1):304. PubMed ID: 34583750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXO3a‑modulated DEPDC1 promotes malignant progression of nephroblastoma via the Wnt/β‑catenin signaling pathway.
    Geng G; Li Q; Guo X; Ni Q; Xu Y; Ma Z; Wang Y; Ming M
    Mol Med Rep; 2022 Aug; 26(2):. PubMed ID: 35795985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of metadherin inhibits cell proliferation and migration in colorectal cancer.
    Li JW; Huang CZ; Li JH; Yuan JH; Chen QH; Zhang WF; Xu ZS; Liu YP; Li Y; Zhan MX; Lu LG
    Oncol Rep; 2018 Oct; 40(4):2215-2223. PubMed ID: 30015962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulated LINC01088 facilitates malignant phenotypes and immune escape of colorectal cancer by regulating microRNAs/G3BP1/PD-L1 axis.
    Li C; Pan B; Wang X; Liu X; Qin J; Gao T; Sun H; Pan Y; Wang S
    J Cancer Res Clin Oncol; 2022 Aug; 148(8):1965-1982. PubMed ID: 35357586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.